Mortality of veteran participants in the crossroads nuclear test
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Washington, D.C. :
National Academy Press
1996.
|
| Edición: | 1st ed |
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820304506719 |
Tabla de Contenidos:
- Mortality of Veteran Participants in the Crossroads Nuclear Test
- Copyright
- Preface
- Acknowledgments
- Glossary and Acronyms
- Contents
- Summary
- 1 Study Rationale and Overview
- RATIONALE
- OVERVIEW
- 2 Other Studies of the Human Health Effects of Radiation Exposure
- 3 Epidemiology Primer
- CHOICE OF COMPARISON GROUP
- FINE TUNING OF EXPOSED GROUP
- CONFOUNDERS
- DATA COLLECTION
- INTERPRETING DATA FINDINGS
- EPIDEMIOLOGY SUMMARY RELATED TO THIS STUDY
- 4 Description of Operation Crossroads
- 5 Data Sources for the Crossroads Study
- 6 The Participant Cohort
- INDEPENDENT VERIFICATION OF PARTICIPANT COHORT
- EXCLUSION OF "POST-CROSSROADS" PARTICIPANTS
- CROSSROADS PARTICIPANTS WHO PARTICIPATED IN OTHER NUCLEAR TESTS
- PRIMARY ANALYSIS-NAVY PERSONNEL ONLY
- EXCLUSIVITY OF PARTICIPANT AND COMPARISON COHORTS
- 7 The Comparison Cohort
- COMPARISON COHORT SELECTION
- Navy and Shipboard Marines
- Army and Army Air Corps
- MILITARY PERSONNEL RECORDS
- ADDITIONAL CONTROLS
- 8 Exposure Definition, Measurement, and Verification
- INTRODUCTION
- DOSIMETRY BACKGROUND
- Definition of Potential Surrogate Dose Groups
- DNA-Provided Dose Estimates
- Overall
- Alternatives
- PARTICIPANT VERSUS NONPARTICIPANT COHORTS AS AN EXPOSURE SURROGATE
- BOARDERS VERSUS NONBOARDING PARTICIPANTS VERSUS NONPARTICIPANTS AS EXPOSURE SURROGATES
- ENGINEERING &
- HULL VERSUS OTHER SPECIALTY STATUS AS AN EXPOSURE SURROGATE
- RELATIONSHIPS OF SURROGATES WITH DNA DOSE DATA
- DECISIONS FOR THE ANALYSES IN THIS REPORT
- 9 Mortality Ascertainment
- PROCEDURE
- Vital Status Ascertainment
- Cause and Date-of-Death Ascertainment
- SUMMARY OF MORTALITY ASCERTAINMENT QUALITY AND ITS POTENTIAL EFFECTS ON VALID INTERPRETATION OF THE...
- 10 Characterization of the Cohorts and Analysis Plan
- DATA DECISIONS TAKEN BEFORE ANALYSIS.
- Restricting Data Elements or Sample Definition
- Data Cleaning and Variable Development
- UNIVARIATE DESCRIPTIONS OF STUDY POPULATION
- MISSING DATA
- Imputation of Fact and Date of Death
- Imputation of Date of Birth
- Summary
- COMPLETENESS OF VITAL STATUS ASCERTAINMENT
- MORTALITY COMPARISONS
- MULTIVARIATE ANALYSES
- Cox Proportional Hazards Model
- Standardized Mortality Ratios
- ANALYSIS OF ARMY (INCLUDING ARMY AIR CORPS) AND MARINE DATA
- NOT THE SUBJECT OF ANALYSIS IN THIS REPORT
- 11 Findings and Discussion
- ORGANIZATION
- FINDINGS: DISPLAYED IN TABLES
- NARRATIVE SUMMARY OF FINDINGS
- Participant Status
- Boarder Status/Hypothesized Exposure Gradient
- Engineering &
- Hull Status/Hypothesized Exposure Surrogate
- FINDINGS FOR MARINES AND ARMY (INCLUDING ARMY AIR CORPS) PERSONNEL
- DISCUSSION
- Boarders
- Engineering &
- Hull
- Discussion of Other Findings
- Other Models and Parameters Considered During Analysis
- STANDARDIZED MORTALITY RATIOS
- DISCUSSION RRELATING THESE FINDINGS TO THOSE OF SIMILAR STUDIES
- Findings in Other Studies of Atomic Veterans
- Selection Bias as an Explanation for Increased Participant All-Cause Mortality
- AVENUES OF FURTHER EXPLORATION
- 12 Conclusions
- SUMMARY OF FINDINGS
- References
- A National Association of Atomic Veterans (NAAV) Medical Survey
- B Participant Description (DNA Memorandum dated July 11, 1994)
- EXPLANATORY MEMORANDUM
- Background
- Operational Period and Operational Area
- SOURCES OF PARTICIPANT INFORMATION
- TRACKING OF PARTICIPANTS
- REFINEMENT OF THE INITIAL DATA BASE
- PARTICIPATION DATES AND DOSE RECONSTRUCTING
- DOSE RECONSTRUCTION
- ENGINEER RATINGS
- SOURCE CODES
- PARTICIPATING UNIT/PERMANENT UNIT DATA
- COMMANDER JOINT TASK FORCE (CJTF-1) MEDICAL RESEARCH PERSONNEL, BOARDING TEAM AND RADSAFE TEAMS.
- C Standardized Mortality Ratios
- D Radiation Doses for CROSSROADS Participants and Exposure Surrogate Groups
- E Verification of Completeness and Accuracy of the Participant Roster
- INTRODUCTION
- METHODOLOGY
- Comparison to Previous Versions of the Participant Roster
- Comparison of Participant Roster to National Association of Atomic Veterans (NAAV) Mortality Study List
- Comparison of DNA Participant Roster to a List of Participants Solicited through Veterans' Journals
- Individual Follow-Up on Putative Participants of Uncertain Status
- RESULTS
- Comparison with an Earlier Version of the Participant Roster
- Comparison with the NAAV Medical Survey
- Comparison with the Write-in List
- Follow-Up on Putative Participants of Uncertain Status
- DISCUSSION
- CONCLUSION
- F Verification of Completeness and Accuracy of Mortality Ascertainment
- ASSESSMENT OF COMPLETENESS
- Completeness of Mortality Follow-Up
- ASSESSMENT OF VALIDITY
- Mortality Ascertainment
- HCFA
- NDI
- EXTERNAL VALIDATION DISCUSSION
- Mortality Information
- Cause-of-Death Information.
